Global Antibiotics Technologies and Markets, 2018-2019 Data, 2020 Estimates & Forecasts to 2025

News provided by

Jan 13, 2021, 07:00 ET

DUBLIN, Jan. 13, 2021 /PRNewswire/ -- The "Antibiotics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The global market for antibiotics should grow from $44.4 billion in 2020 to reach $65.4 billion by 2025 at a compound annual growth rate (CAGR) of 8.1% during the period of 2020-2025.

The report focuses on newer drugs and innovations in chemical compounds, vaccines and biologicals, recently launched or in development. Specifically excluded from the scope of research are vector or mosquito control approaches, strategies and products; drugs used for symptomatic treatment and not for the elimination of the virus from the host; and details on manufacturers and suppliers of non-branded generics.

The antibiotics market growth outlook is positive with significant growth potential for cell wall inhibitor and protein inhibitor antibiotic drugs. There is pressure on antibiotic drug manufacturers to offer antimicrobial-resistant drugs at affordable prices. At the same time, factors such as rising disposable incomes and increasing spending on healthcare in emerging markets, increasing grants from government agencies for antibiotic drugs research and development, and rising incidence of infectious diseases are contributing to the growth of the market.

Pharmaceutical companies and governments are increasingly working together in partnerships and collaborations to provide funding and implement incentive programs for the research and development (R&D) of antibiotics. These partnerships provide financial and technical assistance across different clinical development phases to the pharmaceutical companies.

Various programs, such as the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), the Innovative Medicines Initiative's (IMI's) New Drugs for Bad Bugs (ND4BB) program, Biomedical Advanced Research and Development Authority's (BARDA) Broad Spectrum Antimicrobials Program, and Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), have been implemented for the development of novel antibiotics by focusing on R&D gaps.

This report will also highlight the current and future market potentiality of antibiotics with detailed analysis of competitive environment between the companies. Drivers, restraints, opportunities, pricing analysis, impact of COVID-19, other infectious diseases and a regulatory scenario assessment will be covered in the current report. The report covers a market projection for 2025, and a market share for key players.

The report segments the market for antibiotics based on product type, route of administration, application and geography. Based on product type, the market is segmented into cell wall inhibitors, protein inhibitors, DNA inhibitors and other inhibitors (RNA, Mycolic Acid, Folic Acid). Based on route of administration, the market is segmented into oral and topical. The market is also presented based on application type, which is further segmented into human and veterinary.

By geography, the market has been segmented into the North America, Europe, Asia-Pacific, South America, and Middle East and Africa regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast value for 2025.

The report includes:

28 data tables and 16 additional tables
Comprehensive overview of the global market for antibiotics within the pharmaceutical industry
Analyses of the global market trends, with data corresponding to market size for 2018-2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
Latest information on market growth drivers and opportunities, industry supply chain structure, regulatory developments, technological advancements, and demographic shifts shaping the overall antibiotics marketplace
Evaluation of market growth during the forecast period, and deep dive of market share analysis data basis of product type, product, route of administration, end-user and geographical region
Country specific data and analysis for the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa
Impact of COVID-19 on the pharmaceutical market for antibiotics and an outlook of short-term vs. long-term impacts of COVID-19 pandemic
Identification of the companies best positioned to meet the global market demand for antibiotic drugs on the basis of their proprietary technologies, M&A deals, collaborations, JVs and other strategic alliances
Detailed company profiles of the major global corporations, including Abbott, F. Hoffmann-La Roche AG, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Pfizer and Sanofi

Key Topics Covered:

Chapter 1: Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

Overview of Antibiotics
Common Side Effects of Antibiotics
Classification of Antibiotics
Cell Wall Inhibitors
Protein Inhibitors
DNA Inhibitors
Other Antibiotic Classes
Overview of Gram-negative and Gram-positive Bacteria
Route of Administration
Trends in the Market for Antibiotics
Funding for New Antibiotic Development
Increasing Focus on Antibiotic Drug Development by Smaller Pharmaceutical Firms
Growing Public-Private Partnerships

Chapter 4: Market Dynamics

Market Drivers
Growth of the Global Pharmaceutical Market Driven by Antibiotics
Rise in Geriatric Population and Infection Rate
Increasing Prevalence of Hospital-acquired Infections
Improved Awareness about Diseases and their Antibiotics
Market Restraints
Antibiotic-resistant Infections
Genericization of Antibiotics and Drugs
Declining Research and Development (R&D) Investment
Side Effects of Antibiotics
Market Opportunities
Market Expansion into Emerging Countries
Development of Novel Antibacterial Agents

Chapter 5: Market Breakdown by Product

Global Market for Antibiotics by Product
Cell Wall Inhibitors
Protein Inhibitors
DNA Inhibitors
Other Types of Inhibitors

Chapter 6: Market Breakdown by Route of Administration

Global Market for Antibiotics by Route of Administration
Oral Antibiotics
Topical Antibiotics
Other Routes of Administration

Chapter 7: Market Breakdown by Region

Chapter 8: Impact of COVID-19 on the Pharmaceutical Industry

Short-term Impact
Change in Demand
Shift of Communication and Promotions to Remote Interactions
Research and Development Changes
Long-term Impact
Delayed Approvals for Non-COVID-related Pharmaceutical Products
Self-sufficiency in Pharma Industry
Pharmaceutical Industry Growth Slow-Down
Changes in Consumption Trends in Health-related Products

Chapter 9: Clinical Developments and Pipeline Products

Respiratory Tract Infections

Chapter 10: Value Chain Analysis

China is a Becoming a Center of Microbial Threats

Chapter 11: Regulatory Scenario

FDA and International Regulation
Recent Regulatory Reforms
Ketek Case Study

Chapter 12: Competitive Landscape

Global Company Market Share Analysis
Mergers, Collaborations, Partnerships and Acquisitions

Chapter 13: Company Profiles

Abbott
F. Hoffmann-La Roche AG
Glaxosmithkline Plc
Johnson & Johnson
Merck & Co., Inc.
Mylan N.V.
Pfizer Inc.
Sanofi

For more information about this report visit https://www.researchandmarkets.com/r/7jdfck

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets